Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2019-11-22 00:10 2019-11-20 BSX BOSTON SCIENTIFIC CORP Sorenson John Bradley Officer SELL $42.58 4,800 $204,393 37,585
2019-11-21 00:30 2019-11-20 MOTS Motus GI Holdings Inc. Moran Timothy P. Director, Officer BUY $1.54 10,000 $15,400 217,981
2019-11-21 02:49 2019-11-18 SIBN SI-BONE, Inc. Pisetsky Michael A Officer SELL $17.54 1,254 $22,000 17,583
2019-11-21 00:08 2019-11-18 RMD RESMED INC Douglas Robert Andrew Officer SELL $146.70 1,360 $199,512 154,026
2019-11-21 01:58 2019-11-18 ATEC Alphatec Holdings, Inc. Hunsaker Craig E Officer SELL $7.25 32,000 $232,000 797,448
2019-11-21 04:23 2019-11-18 PEN Penumbra Inc Pray James Robert Officer SELL $167.53 5,333 $893,425 464,099
2019-11-21 02:15 2019-11-18 IRMD IRADIMED CORP JOHNSON BRENT Officer OPT+S $23.11 18,000 $415,980 1,368
2019-11-21 02:49 2019-11-18 SIBN SI-BONE, Inc. FRANCIS LAURA Officer SELL $17.50 2,550 $44,613 88,567
2019-11-19 16:01 2019-11-18 MOTS Motus GI Holdings Inc. Jacobs Gary E. Director BUY $1.54 17,000 $26,180 771,289
2019-11-20 00:15 2019-11-18 INSP Inspire Medical Systems, Inc. Ban Randy Officer OPT+S $63.15 6,390 $403,529 900
2019-11-19 20:56 2019-11-18 SYK STRYKER CORP Scannell Timothy J Officer OPT+S $206.28 4,666 $962,510 155,550
2019-11-20 00:22 2019-11-15 NVCR NovoCure Ltd GROENHUYSEN WILHELMUS CM Officer OPT+S $83.87 25,832 $2,166,563 87,179
2019-11-20 00:44 2019-11-15 UFPT UFP TECHNOLOGIES INC LATAILLE RONALD J Officer SELL $42.54 5,500 $233,970 61,854
2019-11-20 00:24 2019-11-15 NVCR NovoCure Ltd LEUNG GABRIEL Director OPT+S $84.12 20,000 $1,682,354 69,504
2019-11-20 00:40 2019-11-15 STIM Neuronetics, Inc. Furlong Stephen Officer BUY $4.49 22,959 $103,086 88,934
2019-11-20 00:12 2019-11-19 UTMD UTAH MEDICAL PRODUCTS INC PAYNE BARBARA A Director SELL $102.25 694 $70,962 18,838
2019-11-20 00:08 2019-11-15 PODD INSULET CORP Fallon John A. Director OPT+S $180.95 14,525 $2,628,244 13,469
2019-11-20 00:43 2019-11-19 CRY Artivion Inc. McCall Ronald D Director SELL $24.64 4,000 $98,565 132,599
2019-11-19 02:01 2019-11-14 XAIR Beyond Air, Inc. Lisi Steven A. Director, Officer BUY $4.07 20,000 $81,312 631,318
2019-11-19 02:50 2019-11-15 RMD RESMED INC Hollingshead James Officer OPT+S $146.35 20,038 $2,932,561 82,349
2019-11-19 03:12 2019-11-18 TNDM TANDEM DIABETES CARE INC Vosseller Leigh Officer OPT+S $65.41 10,000 $654,128 3,265
2019-11-19 00:10 2019-11-13 XAIR Beyond Air, Inc. BECK DOUGLAS Officer BUY $3.98 1,569 $6,245 15,460
2019-11-19 00:07 2019-11-14 ECIA ENCISION INC FRIES ROBERT H Director BUY $0.50 20,000 $10,000 250,000
2019-11-18 22:21 2019-11-14 UFPT UFP TECHNOLOGIES INC OBERDORF THOMAS Director SELL $42.94 2,754 $118,257 52,354
2019-11-19 03:45 2019-11-14 STIM Neuronetics, Inc. Farley Brian E Director BUY $4.48 30,000 $134,370 147,606
2019-11-18 20:13 2019-11-18 NEPH NEPHROS INC Astor Andrew Officer BUY $8.38 750 $6,282 61,460
2019-11-18 20:12 2019-11-18 NEPH NEPHROS INC Evans Daron Director, Officer BUY $8.35 1,000 $8,350 119,933
2019-11-18 19:27 2019-11-15 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $1.38 2,136 $2,946 14,440,532
2019-11-15 20:51 2019-11-14 PETV PetVivo Holdings, Inc. Martin James Rudolph Director BUY $0.40 10,000 $4,000 89,938
2019-11-16 00:30 2019-06-03 XAIR Beyond Air, Inc. Forbes William P Director BUY $5.15 4,855 $25,003 4,855
2019-11-16 00:25 2019-11-13 NVCR NovoCure Ltd GROENHUYSEN WILHELMUS CM Officer OPT+S $81.28 67,576 $5,492,307 87,179
2019-11-16 01:44 2019-11-13 IRMD IRADIMED CORP JOHNSON BRENT Officer OPT+S $23.33 18,000 $419,940 1,368
2019-11-14 20:25 2019-11-13 MMM 3M CO Silberhorn Ty R Officer OPT+S $170.72 1,634 $278,950 333
2019-11-15 01:12 2019-06-03 XAIR Beyond Air, Inc. Lee Yoori Director BUY $5.15 4,855 $25,003 7,197
2019-11-15 00:15 2019-06-03 XAIR Beyond Air, Inc. Lisi Steven A. Director, Officer BUY $4.80 88,253 $423,544 611,318
2019-11-15 00:15 2019-06-03 XAIR Beyond Air, Inc. Avniel Amir Director, Officer BUY $5.15 9,709 $50,001 462,324
2019-11-14 21:54 2019-11-12 UFPT UFP TECHNOLOGIES INC OBERDORF THOMAS Director SELL $43.71 7,246 $316,709 55,108
2019-11-14 18:18 2019-11-13 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $1.30 2,000 $2,594 14,438,396
2019-11-14 01:24 2019-11-11 HAE HAEMONETICS CORP Bolorforosh Said Officer SELL $118.27 339 $40,094 1,977
2019-11-14 01:19 2019-11-08 ECIA ENCISION INC Trudel Gregory J. Director, Officer BUY $0.40 20,050 $7,940 30,475
2019-11-14 04:57 2019-11-08 TELA TELA Bio, Inc. Zuga Matt Director BUY $13.00 86,121 $1,119,573 260,808
2019-11-14 04:52 2019-11-08 TELA TELA Bio, Inc. Azarbarzin Kurt Director BUY $13.00 86,121 $1,119,573 260,808
2019-11-14 05:03 2019-11-08 TELA TELA Bio, Inc. Quaker BioVentures II LP 10% owner BUY $13.00 153,846 $1,999,998 888,664
2019-11-14 03:47 2019-11-11 RMD RESMED INC Farrell Michael J. Officer OPT+S $143.94 6,651 $957,337 313,416
2019-11-14 00:14 2019-11-13 CRY Artivion Inc. Mackin James P Officer BUY $23.47 5,000 $117,355 225,731
2019-11-14 04:48 2019-11-08 TELA TELA Bio, Inc. Oliva Adele C Director, 10% owner BUY $13.00 153,846 $1,999,998 888,664
2019-11-14 05:03 2019-11-11 PEN Penumbra Inc Elsesser Adam Director, Officer SELL $168.70 8,000 $1,349,578 1,058,982
2019-11-14 02:20 2019-11-08 XAIR Beyond Air, Inc. BECK DOUGLAS Officer BUY $4.05 4,181 $16,938 13,891
2019-11-14 02:08 2019-06-03 XAIR Beyond Air, Inc. BECK DOUGLAS Officer BUY $5.15 9,710 $50,007 9,710
2019-11-14 00:30 2019-11-11 NVCR NovoCure Ltd GROENHUYSEN WILHELMUS CM Officer OPT+S $80.16 48,600 $3,895,927 87,179
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.